Study the efficacy of intralesional pentoxifylline versus triamcinolone acetonide in keloid scars patients

Keloids are prevalent fibro-proliferative tumors, and treating them is still a challenge although intralesional injections of triamcinolone acetonide (TAC) are effective, they have frequently linked adverse effects. Pentoxifylline (PTX) is an anti-fibrotic and anti-inflammatory, and vasodilator. It has not yet been tested for intralesional injection in keloids. The aim of the study is to study the efficacy of intralesional pentoxifylline versus triamcinolone acetonide in keloid scars of 40 patients. In this study, 40 patients with keloid scars regardless of the cause of keloid born, 20 patients have injected with intralesional triamcinolone acetonide, and 20 patients with intralesional pentoxifylline every two weeks until the lesion flatted or a maximum 6 sessions. Evaluation of Patient response to treatment was done by utilizing the verbal rating scale and Vancouver scar scale. Between groups A& B there is no statistically significant difference in height, color, the surface of the keloid, pigmentation consistency, verbal rating scale, visual analog scale (improvement in keloid), patient satisfaction, and several sessions for best results